SEC Form 4 · accession 0001140361-17-021248
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Eric Davis
Officer — EVP, General Counsel
Period of report
May 15, 2017
Accepted (ET)
May 17, 2017 · 6:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2017 | F | 1,096 | $91.50 | D | 84,155 | D | |
| Common Stock | May 16, 2017 | M | 1,146 | $14.39 | A | 85,301 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy Common Stock)F1 | $14.39 | May 16, 2017 | M | 1,146 | D | Nov 12, 2009 | May 11, 2019 | Common Stock | 1,146 | 0 | D |
Explanation of responses
- F1Reflects the number of stock options outstanding after the transaction from this specific stock option grant.